Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Akorn Enters Exclusive Manufacturing Pact | Contract Pharma

What are you searching for?

Sign in
Breaking News

Akorn Enters Exclusive Manufacturing Pact

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Akorn, Inc. has entered into a 10-year exclusive contract manufacturing supply agreement with an undisclosed pharmaceutical firm. Under the terms of the agreement, Akorn will be responsible for the manufacturing and supply of several injectable drug products. Akorn anticipates annual contract revenue from these products to be between $4 million and $5 million for the duration of the supply agreement.
   
Arthur S. Przybyl, Akorn’s president and chief executive officer stated, “This agreement reflects Akorn’s commitment to providing high quality contract manufacturing services to the pharmaceutical industry. We look forward to supplying these important drug products from our Decatur, IL facility.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters